In vitro synergism of 4-hydroperoxycyclophosphamide and cisplatin: relevance for bone marrow purging Richard H. PetersCarlene S. BrandonRobert K. Stuart Original Articles Pages: 129 - 134
In vivo activity on murine tumors of a novel antitumor compound, N-β-dimethylaminoethyl 9-carboxy-5-hydroxy-10-methoxybenzo[a]phenazine-6-carboxamide sodium salt (NC-190) Shiro NakaikeTakehiro YamagishiShigeru Tsukagoshi Original Articles Pages: 135 - 139
Comparative effectiveness of mitoxantrone and doxorubicin in overcoming experimentally induced drug resistance in murine and human tumour cell lines in vitro Bridget T. HillLouise K. HoskingRichard D. H. Whelan Original Articles Pages: 140 - 144
Effect of homoharringtonine on the viability of murine leukemia P388 cells resistant to either adriamycin, vincristine, or 1-β-D-arabinofuranosylcytosine Lee J. WilkoffElizabeth A. DulmadgeDaniel P. Griswold Jr. Original Articles Pages: 145 - 150
In vitro effect of liposome-incorporated valinomycin on growth and macromolecular synthesis of normal and ras-transformed 3T3 cells Sayed S. DaoudR. L. Juliano Original Articles Pages: 151 - 155
Pharmacokinetics of methotrexate (MTX) and 7-hydroxymethotrexate (7-OH-MTX) in rats and evidence for the metabolism of MTX to 7-OH-MTX Lutz FahrigHelmut BraschHeiko Iven Original Articles Pages: 156 - 160
Reduced formation of lesions in the DNA of a multidrug-resistant L1210 subline selected for teniposide resistance DeWayne RobertsP. David FoglesongLee Wiggins Original Articles Pages: 161 - 168
Effect on liver tumor growth in rats of allopurinol and 5-fluorouracil in combination with hepatic artery ligation G. CarlssonB. GustavssonLo Hafström Original Articles Pages: 169 - 172
Hypersensitivity reactions to deoxycoformycin Peter J. O'DwyerSusan A. KingDaniel F. Hoth Original Articles Pages: 173 - 175
Pharmacokinetics of tauromustine in cancer patients P. O. GunnarssonJ. Vibe-PetersenJ. F. Smyth Original Articles Pages: 176 - 180
Phase II trial of carboplatin in patients with advanced germ-cell testicular tumors and transitional cell carcinomas of the urinary tract Hideyuki AkazaMasamichi HagiwaraCarboplatin Study Group Original Articles Pages: 181 - 185
A phase I clinical trial of recombinant human tumor necrosis factor given daily for five days Patrick J. CreavenDean E. BrennerApril D. Proefrock Original Articles Pages: 186 - 191
Phase II trial with high-dose ifosfamide and mesna given in a 24-h infusion for advanced GI tract cancer C. FocanJ. BoossyJ. J. Claessens Short Communication Pages: 192 - 193
Elevated plasma tamoxifen levels in a patient with liver obstruction Michael W. DeGregorioValerie J. WiebeWalter M. Holleran Letter to the Editors Pages: 194 - 195